Latest Doherty Institute News | Page 2

How does cell death trigger inflammation?
Could new antibiotic clovibactin beat superbugs? Or will it join the long list of failed drugs?
Using antibacterial lipids in nanoparticles combined with established treatment shows promise against antibiotic resistant bacteria
$6 million for health research that listens to Indigenous communities
New approaches to blood and liver cancer therapies recognised with $2.5 million CSL Centenary Fellowships
New Animal Disease Diagnostic Van Ready To Hit Road
RESEARCH REVEALS HOW COVID-19 VIRUS INFECTS THE PLACENTA, AND HOW THIS CAN BE PREVENTED
Research reveals how covid-19 virus infects the placenta, and how this can be prevented
Who’s taking COVID antivirals like Paxlovid? Hint: it helps if you’re rich
Infectious Disease Institute Now Step Closer
Victoria Hosts Inaugural Quad Fellowship Summit
National Foundation for Australia-China Relations Advisory Board Appointments
Key to fighting chronic inflammation in severe COVID
Victoria And South Africa To Partner On mRNA Vaccines
Study reveals how patients’ smoking history changes evolution of lung cancer
Pregnant this winter? Here’s how to prepare for COVID and get vaccinated
Measles has been identified in NSW, Qld and SA. 5 things to know about the virus
T cells open door to potential immune therapies
MRFF back Monash mRNA researchers
Variant-specific vaccines offer better protection against COVID: new research
Genomics has helped identify a new strep A strain in Australia – and what has made it dangerous
TGA confirms the performance of Australian approved Rapid Antigen Tests with COVID-19 Variants
Twice as many Victorians may have had COVID-19 in January 2022 than reported, new analysis reveals
Breakthrough testing standard developed for Covid RATs
Optimise Study deemed success in directly informing Victoria’s COVID-19 response
Breaking ground: Moderna’s big build begins
Paxlovid is Australia’s first-line COVID antiviral but Lagevrio also prevents severe disease in over-70s
Your handy guide to latest COVID subvariants
Dodging death: Surprise discovery redirects efforts for treatment of liver disease
COVID Nasal Spray Treatment Clinical Trials To Begin
5 virus families that could cause next pandemic, according to experts
Leading Pandemic Therapeutics Centre In Melbourne
Burnet recognises stellar service of departing Board members
Outstanding scientists don’t work alone: collaborations in Asia-Pacific region
Victoria’s first mRNA innovation hub backed by state government
Victoria Investing In World-First mRNA Innovation Hub
Burnet research honoured at AIDS 2022
Decade Long Plan For Home Grown Medical Research To Thrive
Rapid Antigen Test cancellations not due to failure to detect Covid Omicron variant
By June 2022, almost half of adult Australian population is estimated to have had Covid
National antibody study: By June, almost half of Aussies had recently had Covid
Combating drug-resistant bacteria
Mapping ‘energy fingerprints’ of lung cancer leads to fundamental treatment rethink
National antibody study confirms Covid cases higher than reported
How Covid created dramatic changes in ‘winter virus’
Volunteers receive first dose in clinical trial of Melbourne-made Covid vaccines
More natural air ventilation systems for NSW schools
New Fellowship To Continue Fight Against Infectious Diseases